Filter

Refine by collections

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 10 of 110 items for :

  • "neuroendocrine tumors" x
Clear All
Roxanne C S van Adrichem Department of Internal Medicine, Sector of Endocrinology, ENETS Centre of Excellence for Neuroendocrine Tumors, Erasmus MC, Rotterdam, The Netherlands

Search for other papers by Roxanne C S van Adrichem in
Google Scholar
PubMed Close
,
Aart Jan van der Lely Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands

Search for other papers by Aart Jan van der Lely in
Google Scholar
PubMed Close
,
Martin Huisman Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands

Search for other papers by Martin Huisman in
Google Scholar
PubMed Close
,
Piet Kramer Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands

Search for other papers by Piet Kramer in
Google Scholar
PubMed Close
,
Richard A Feelders Department of Internal Medicine, Sector of Endocrinology, ENETS Centre of Excellence for Neuroendocrine Tumors, Erasmus MC, Rotterdam, The Netherlands

Search for other papers by Richard A Feelders in
Google Scholar
PubMed Close
,
Patric J D Delhanty Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands

Search for other papers by Patric J D Delhanty in
Google Scholar
PubMed Close
, and
Wouter W de Herder Department of Internal Medicine, Sector of Endocrinology, ENETS Centre of Excellence for Neuroendocrine Tumors, Erasmus MC, Rotterdam, The Netherlands

Search for other papers by Wouter W de Herder in
Google Scholar
PubMed Close

). Neoplastic effects of ghrelin have been reported as well including: cell proliferation, cell migration, cell invasion, inflammation, apoptosis, and angiogenesis ( 17 , 18 , 19 ). Neuroendocrine tumors (NETs) are rare tumors characterized by the

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-16-0021
Volume/Issue:
Volume 5: Issue 4
Open access
Katherine Van Loon
Search for other papers by Katherine Van Loon in
Google Scholar
PubMed Close
,
Li Zhang
Search for other papers by Li Zhang in
Google Scholar
PubMed Close
,
Jennifer Keiser
Search for other papers by Jennifer Keiser in
Google Scholar
PubMed Close
,
Cendy Carrasco
Search for other papers by Cendy Carrasco in
Google Scholar
PubMed Close
,
Katherine Glass The UCSF Helen Diller Family Comprehensive Cancer Center, The Ohio State University Comprehensive Cancer Center, National Comprehensive Cancer Network, University of California, San Francisco, 1600 Divisadero Street, UCSF Box 1770, San Francisco, California 94143, USA

Search for other papers by Katherine Glass in
Google Scholar
PubMed Close
,
Maria-Teresa Ramirez The UCSF Helen Diller Family Comprehensive Cancer Center, The Ohio State University Comprehensive Cancer Center, National Comprehensive Cancer Network, University of California, San Francisco, 1600 Divisadero Street, UCSF Box 1770, San Francisco, California 94143, USA

Search for other papers by Maria-Teresa Ramirez in
Google Scholar
PubMed Close
,
Sarah Bobiak The UCSF Helen Diller Family Comprehensive Cancer Center, The Ohio State University Comprehensive Cancer Center, National Comprehensive Cancer Network, University of California, San Francisco, 1600 Divisadero Street, UCSF Box 1770, San Francisco, California 94143, USA

Search for other papers by Sarah Bobiak in
Google Scholar
PubMed Close
,
Eric K Nakakura
Search for other papers by Eric K Nakakura in
Google Scholar
PubMed Close
,
Alan P Venook
Search for other papers by Alan P Venook in
Google Scholar
PubMed Close
,
Manisha H Shah The UCSF Helen Diller Family Comprehensive Cancer Center, The Ohio State University Comprehensive Cancer Center, National Comprehensive Cancer Network, University of California, San Francisco, 1600 Divisadero Street, UCSF Box 1770, San Francisco, California 94143, USA

Search for other papers by Manisha H Shah in
Google Scholar
PubMed Close
, and
Emily K Bergsland
Search for other papers by Emily K Bergsland in
Google Scholar
PubMed Close

Introduction Neuroendocrine tumors (NETs) arise from the many cells of the diffuse endocrine system, which possess unique functions and the potential for hormone production. As such, NETs represent a heterogeneous group of tumors with variable

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-14-0119
Volume/Issue:
Volume 4: Issue 1
Open access
Peiwen Wu Department of Radiation Oncology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China

Search for other papers by Peiwen Wu in
Google Scholar
PubMed Close
,
Dongjie He Department of Radiation Oncology, Tangdu Hospital, the Second Affiliated Hospital of Air Force Medical University, Xi’an, China

Search for other papers by Dongjie He in
Google Scholar
PubMed Close
,
Hao Chang Department of Radiation Oncology, Tangdu Hospital, the Second Affiliated Hospital of Air Force Medical University, Xi’an, China

Search for other papers by Hao Chang in
Google Scholar
PubMed Close
, and
Xiaozhi Zhang Department of Radiation Oncology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China

Search for other papers by Xiaozhi Zhang in
Google Scholar
PubMed Close

Background Neuroendocrine tumors (NETs) are a rare group of tumors that develop from neuroendocrine cells and peptidergic neurons with endocrine functions and express neuroendocrine markers. NETs can occur in any body part, but they occur most

Article Type:
Research Article
Collections:
Hormones and Cancer
DOI:
https://doi.org/10.1530/EC-23-0331
Volume/Issue:
Volume 12: Issue 12
Open access
Paweł Komarnicki Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poznań, Poland

Search for other papers by Paweł Komarnicki in
Google Scholar
PubMed Close
,
Paweł Gut Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poznań, Poland

Search for other papers by Paweł Gut in
Google Scholar
PubMed Close
,
Jan Musiałkiewicz Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poznań, Poland

Search for other papers by Jan Musiałkiewicz in
Google Scholar
PubMed Close
,
Maja Cieślewicz Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poznań, Poland

Search for other papers by Maja Cieślewicz in
Google Scholar
PubMed Close
,
Adam Maciejewski Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poznań, Poland

Search for other papers by Adam Maciejewski in
Google Scholar
PubMed Close
,
Prachi Patel Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poznań, Poland

Search for other papers by Prachi Patel in
Google Scholar
PubMed Close
,
George Mastorakos Unit of Endocrinology, Diabetes Mellitus and Metabolism, Aretaieion University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by George Mastorakos in
Google Scholar
PubMed Close
, and
Marek Ruchała Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poznań, Poland

Search for other papers by Marek Ruchała in
Google Scholar
PubMed Close

Introduction Neuroendocrine tumors (NETs) make up a heterogeneous group of neoplasms stemming from the diffuse endocrine system (DES) ( 1 ). Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) represent a subdivision, most commonly

Article Type:
Research Article
Collections:
Cardiovascular
DOI:
https://doi.org/10.1530/EC-23-0249
Volume/Issue:
Volume 12: Issue 10
Open access
Matteo Scopel Medical Clinic III, Department of Medicine (DIMED), University Hospital of Padua, Padua, Italy

Search for other papers by Matteo Scopel in
Google Scholar
PubMed Close
,
Eugenio De Carlo Medical Clinic III, Department of Medicine (DIMED), University Hospital of Padua, Padua, Italy

Search for other papers by Eugenio De Carlo in
Google Scholar
PubMed Close
,
Francesca Bergamo Unit of Medical Oncology 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy

Search for other papers by Francesca Bergamo in
Google Scholar
PubMed Close
,
Sabina Murgioni Unit of Medical Oncology 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy

Search for other papers by Sabina Murgioni in
Google Scholar
PubMed Close
,
Riccardo Carandina Radiodiagnostic Unit, University Hospital of Padua, Padua, Italy

Search for other papers by Riccardo Carandina in
Google Scholar
PubMed Close
,
Anna Rita Cervino Radiotherapy and Nuclear Medicine Unit, Istituto Oncologico Veneto IOV-IRCCS, Padua, Italy

Search for other papers by Anna Rita Cervino in
Google Scholar
PubMed Close
,
Marta Burei Radiotherapy and Nuclear Medicine Unit, Istituto Oncologico Veneto IOV-IRCCS, Padua, Italy

Search for other papers by Marta Burei in
Google Scholar
PubMed Close
,
Federica Vianello Radiotherapy and Nuclear Medicine Unit, Istituto Oncologico Veneto IOV-IRCCS, Padua, Italy

Search for other papers by Federica Vianello in
Google Scholar
PubMed Close
,
Vittorina Zagonel Unit of Medical Oncology 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy

Search for other papers by Vittorina Zagonel in
Google Scholar
PubMed Close
,
Matteo Fassan Surgical Pathology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy

Search for other papers by Matteo Fassan in
Google Scholar
PubMed Close
, and
Roberto Vettor Medical Clinic III, Department of Medicine (DIMED), University Hospital of Padua, Padua, Italy

Search for other papers by Roberto Vettor in
Google Scholar
PubMed Close

Introduction Neuroendocrine tumors (NETs) are a heterogeneous family of neoplasms that originate from cells belonging to the widespread neuroendocrine system. These cells appear to be ubiquitous in the human body, but the main sites are the

Article Type:
Research Article
Collections:
Hormones and Cancer
DOI:
https://doi.org/10.1530/EC-21-0568
Volume/Issue:
Volume 11: Issue 7
Open access
Elham Barazeghi Department of Surgical Sciences, Uppsala University, Uppsala University Hospital, Rudbeck Laboratory, Uppsala, Sweden

Search for other papers by Elham Barazeghi in
Google Scholar
PubMed Close
,
Per Hellman Department of Surgical Sciences, Uppsala University, Uppsala University Hospital, Rudbeck Laboratory, Uppsala, Sweden

Search for other papers by Per Hellman in
Google Scholar
PubMed Close
,
Gunnar Westin Department of Surgical Sciences, Uppsala University, Uppsala University Hospital, Rudbeck Laboratory, Uppsala, Sweden

Search for other papers by Gunnar Westin in
Google Scholar
PubMed Close
, and
Peter Stålberg Department of Surgical Sciences, Uppsala University, Uppsala University Hospital, Rudbeck Laboratory, Uppsala, Sweden

Search for other papers by Peter Stålberg in
Google Scholar
PubMed Close

Introduction Small intestinal neuroendocrine tumors (SI-NETs) arise from enterochromaffin cells in the gastrointestinal tract, which are small and slow-growing (Ki67 proliferation index is often <2%) tumors with annual incidence of 1 per 100

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-19-0279
Volume/Issue:
Volume 8: Issue 8
Open access
Hanbaro Kim Department of Surgery, Hallym University College of Medicine, Chuncheon, Republic of Korea

Search for other papers by Hanbaro Kim in
Google Scholar
PubMed Close
,
Ki Byung Song Division of Hepatobilliary and Pancreatic Surgery, Department of Surgery, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Republic of Korea

Search for other papers by Ki Byung Song in
Google Scholar
PubMed Close
,
Dae Wook Hwang Division of Hepatobilliary and Pancreatic Surgery, Department of Surgery, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Republic of Korea

Search for other papers by Dae Wook Hwang in
Google Scholar
PubMed Close
,
Jae Hoon Lee Division of Hepatobilliary and Pancreatic Surgery, Department of Surgery, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Republic of Korea

Search for other papers by Jae Hoon Lee in
Google Scholar
PubMed Close
,
Shadi Alshammary Department of Surgery, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia

Search for other papers by Shadi Alshammary in
Google Scholar
PubMed Close
, and
Song Cheol Kim Division of Hepatobilliary and Pancreatic Surgery, Department of Surgery, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Republic of Korea

Search for other papers by Song Cheol Kim in
Google Scholar
PubMed Close

Introduction Pancreatic neuroendocrine tumors (PNETs), also known as islet cell tumors, are rare neoplasms arising from the endocrine pancreas, with a reported incidence of <1 per 100,000 persons per year ( 1 , 2 ). However, the incidence of

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-19-0282
Volume/Issue:
Volume 8: Issue 7
Open access
Olof Joakim Pettersson Radiology and Molecular Imaging, Uppsala University Hospital, Uppsala, Sweden
Department of Surgical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Olof Joakim Pettersson in
Google Scholar
PubMed Close
,
Katarzyna Fröss-Baron Radiology and Molecular Imaging, Uppsala University Hospital, Uppsala, Sweden
Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Katarzyna Fröss-Baron in
Google Scholar
PubMed Close
,
Joakim Crona Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Joakim Crona in
Google Scholar
PubMed Close
, and
Anders Sundin Radiology and Molecular Imaging, Uppsala University Hospital, Uppsala, Sweden
Department of Surgical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Anders Sundin in
Google Scholar
PubMed Close

Introduction Gastroenteropancreatic neuroendocrine tumors comprise a variety of tumors, originating from stem cells in the gastrointestinal canal and pancreatic islets. An incidence of approximately 5 per 100,000 person-years is often

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-21-0027
Volume/Issue:
Volume 10: Issue 4
Open access
Kazhan Mollazadegan Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Kazhan Mollazadegan in
Google Scholar
PubMed Close
,
Britt Skogseid Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Britt Skogseid in
Google Scholar
PubMed Close
,
Johan Botling Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden

Search for other papers by Johan Botling in
Google Scholar
PubMed Close
,
Tobias Åkerström Department of Surgical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Tobias Åkerström in
Google Scholar
PubMed Close
,
Barbro Eriksson Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Barbro Eriksson in
Google Scholar
PubMed Close
,
Staffan Welin Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Staffan Welin in
Google Scholar
PubMed Close
,
Anders Sundin Department of Surgical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Anders Sundin in
Google Scholar
PubMed Close
, and
Joakim Crona Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Joakim Crona in
Google Scholar
PubMed Close

grading of panNENs ( 3 ), high-grade neoplasms were separated into two categories: well-differentiated (WD) pancreatic neuroendocrine tumor grade 3 (panNET-G3) and poorly differentiated (PD) NEC ( 4 ). PanNET-G3 frequently harbors mutations in MEN1 and

Article Type:
Research Article
Collections:
Hormones and Cancer
DOI:
https://doi.org/10.1530/EC-21-0604
Volume/Issue:
Volume 11: Issue 3
Open access
R C S van Adrichem
Search for other papers by R C S van Adrichem in
Google Scholar
PubMed Close
,
L J Hofland
Search for other papers by L J Hofland in
Google Scholar
PubMed Close
,
R A Feelders
Search for other papers by R A Feelders in
Google Scholar
PubMed Close
,
M C De Martino
Search for other papers by M C De Martino in
Google Scholar
PubMed Close
,
P M van Koetsveld
Search for other papers by P M van Koetsveld in
Google Scholar
PubMed Close
,
C H J van Eijck Department of Internal Medicine, Department of Surgery, Department of Pathology, Sector of Endocrinology, Erasmus MC, ‘s Gravendijkwal 230, Room D-430, 3015 CE Rotterdam, The Netherlands

Search for other papers by C H J van Eijck in
Google Scholar
PubMed Close
,
R R de Krijger Department of Internal Medicine, Department of Surgery, Department of Pathology, Sector of Endocrinology, Erasmus MC, ‘s Gravendijkwal 230, Room D-430, 3015 CE Rotterdam, The Netherlands

Search for other papers by R R de Krijger in
Google Scholar
PubMed Close
,
D M Sprij-Mooij
Search for other papers by D M Sprij-Mooij in
Google Scholar
PubMed Close
,
J A M J L Janssen
Search for other papers by J A M J L Janssen in
Google Scholar
PubMed Close
, and
W W de Herder
Search for other papers by W W de Herder in
Google Scholar
PubMed Close

Introduction Gastroenteropancreatic neuroendocrine tumors (GEP NETs) are rare and heterogeneous tumors which may vary according to their biological, functional, and clinical behavior (1) . Chromogranin A (CgA) and the Ki-67 proliferation index are

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-13-0052
Volume/Issue:
Volume 2: Issue 4
Open access